What are the differences in formal requirements between clinical trials and observational studies?
The differences in formal requirements between clinical trials and observational studies arise primarily from the distinct nature of these projects, the level of intervention in standard medical practice, and the degree of risk for participants. Although both types of studies aim to generate reliable medical data, they are subject to different regulatory frameworks and require different formal procedures already at the planning and initiation stages. A clear understanding of these differences helps avoid incorrect study classification, administrative delays, and regulatory risks.
Interventional clinical trials are subject to strict legal regulations, in particular Regulation (EU) No 536/2014, ICH GCP guidelines, and national legal acts. They require authorization from the competent authority and a positive opinion from an ethics committee before the first participant can be enrolled. A key formal requirement is the submission of a complete application via the CTIS system, including a detailed study protocol, investigational medicinal product documentation, a benefit–risk assessment, a safety monitoring plan, and extensive quality documentation. Clinical trials also require strict adverse event reporting, ongoing monitoring, audits, and the maintenance of complete study documentation for the legally defined archiving period.
Observational studies, including non-interventional studies, are characterized by a significantly lower level of formalization. Patient treatment follows routine clinical practice, and therapeutic decisions are not dictated by the study protocol. As a result, observational studies generally do not require authorization from a competent authority or registration in the CTIS system. However, it is recommended to obtain approval from an ethics committee, prepare an observational study protocol, and ensure compliance with data protection regulations, including GDPR, GCP, GPP, and GVP. The scope of documentation is more limited, and participant safety obligations mainly involve reporting events in accordance with the project’s internal procedures and applicable national law.
Another important difference concerns the Sponsor’s responsibility and the level of oversight. In clinical trials, the Sponsor is responsible for the quality, safety, and integrity of data throughout the entire study lifecycle, which entails the implementation of a quality management system, monitoring, and compliance control in line with GCP. In observational studies, this responsibility is more limited and focuses primarily on the reliability of collected data and methodological transparency. There is usually no obligation to conduct classical monitoring or to report to regulatory systems such as CTIS.
Correctly distinguishing between a clinical trial and an observational study is of key strategic importance. Incorrect classification may result in study suspension, additional formal requirements, or challenges to the credibility of the results. Therefore, already at the study concept stage, it is advisable to conduct a regulatory analysis and ensure that the planned activities align with the appropriate study category.
If you are planning a research project and are unsure whether it qualifies as a clinical trial or an observational study, take advantage of a free consultation with our team. We will help you correctly classify the study, select the appropriate regulatory pathway, and safely conduct the project in compliance with applicable regulations.
